Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

MedPlus

Biotech & Life Sciences · Hyderabad, India · Founded 2006 · IPO 2021 Thoroughbred

We are India's Favorite Pharmacy

Valuation
$1.50B
Market cap · May/2026
Revenue
$833M
Latest reported FY
EBITDA
$81M
Latest reported FY

Investors

4 investors on MedPlus's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 4 investors entered at this stage
TVS Capital Funds
Mount Kellett Capital Management
Warburg Pincus
Peepul Capital

Global footprint

Where MedPlus has talent and traffic

Workforce by country
18 countries with
team presence
🇮🇳 India97.3%
🇳🇬 Nigeria0.7%
🇦🇪 United Arab Emirates0.4%
🇺🇸 United States0.4%
🇦🇺 Australia0.1%
Top 5 of 18 shown
Web traffic by country
34K monthly visits
across markets
🇮🇳 India90%
🇺🇸 United States9.1%
Top 2 markets shown

Market sentiment

What the market is saying about MedPlus

An AI-synthesized read of the highest-engagement posts about MedPlus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See MedPlus on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.